Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Oncotelic Therapeutics, Inc. (OTLC) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Oncotelic Therapeutics, Inc. (OTLC), most recent 12 months reported: net income $247.5M. Latest balance sheet on file: liquid cash $186.01K, total debt $13.89M, net cash -$13.71M. From SEC filings. Others in Pharmaceutical Preparations: ONCOLYTICS BIOTECH INC. · ORIC PHARMACEUTICALS, INC. · Oruka Therapeutics, Inc. · OS THERAPIES INCORPORATED · Processa Pharmaceuticals, Inc. · PDS Biotechnology Corporation · PEPGEN INC. · Phio Pharmaceuticals Corp.

Stock screener

Watchlist